140 related articles for article (PubMed ID: 33657857)
1. CCM2L (Cerebral Cavernous Malformation 2 Like) Deletion Aggravates Cerebral Cavernous Malformation Through Map3k3-KLF Signaling Pathway.
Choi JP; Yang X; He S; Song R; Xu ZR; Foley M; Wong JJ; Xu CR; Zheng X
Stroke; 2021 Apr; 52(4):1428-1436. PubMed ID: 33657857
[TBL] [Abstract][Full Text] [Related]
2. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
3. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
4. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation.
Huo R; Yang Y; Sun Y; Zhou Q; Zhao S; Mo Z; Xu H; Wang J; Weng J; Jiao Y; Zhang J; He Q; Wang S; Zhao J; Wang J; Cao Y
Angiogenesis; 2023 May; 26(2):295-312. PubMed ID: 36719480
[TBL] [Abstract][Full Text] [Related]
5. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
[TBL] [Abstract][Full Text] [Related]
6. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
7. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.
Zhou Z; Rawnsley DR; Goddard LM; Pan W; Cao XJ; Jakus Z; Zheng H; Yang J; Arthur JS; Whitehead KJ; Li D; Zhou B; Garcia BA; Zheng X; Kahn ML
Dev Cell; 2015 Jan; 32(2):168-80. PubMed ID: 25625206
[TBL] [Abstract][Full Text] [Related]
8. Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction.
Chrzanowska-Wodnicka M
Exp Cell Res; 2013 Sep; 319(15):2350-9. PubMed ID: 23911990
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis provides new molecular signatures in sporadic Cerebral Cavernous Malformation endothelial cells.
Scimone C; Donato L; Alibrandi S; Esposito T; Alafaci C; D'Angelo R; Sidoti A
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165956. PubMed ID: 32877751
[TBL] [Abstract][Full Text] [Related]
10. CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.
Castro M; Laviña B; Ando K; Álvarez-Aznar A; Abu Taha A; Brakebusch C; Dejana E; Betsholtz C; Gaengel K
Circ Res; 2019 Apr; 124(8):1240-1252. PubMed ID: 30732528
[TBL] [Abstract][Full Text] [Related]
11. Novel Chronic Mouse Model of Cerebral Cavernous Malformations.
Cardoso C; Arnould M; De Luca C; Otten C; Abdelilah-Seyfried S; Heredia A; Leutenegger AL; Schwaninger M; Tournier-Lasserve E; Boulday G
Stroke; 2020 Apr; 51(4):1272-1278. PubMed ID: 31992178
[TBL] [Abstract][Full Text] [Related]
12. Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study.
Oldenburg J; Malinverno M; Globisch MA; Maderna C; Corada M; Orsenigo F; Conze LL; Rorsman C; Sundell V; Arce M; Smith RO; Yau ACY; Billström GH; Mägi CÖ; Beznoussenko GV; Mironov AA; Fernando D; Daniel G; Olivari D; Fumagalli F; Lampugnani MG; Dejana E; Magnusson PU
Stroke; 2021 Apr; 52(4):1418-1427. PubMed ID: 33618555
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
Ren AA; Snellings DA; Su YS; Hong CC; Castro M; Tang AT; Detter MR; Hobson N; Girard R; Romanos S; Lightle R; Moore T; Shenkar R; Benavides C; Beaman MM; Müller-Fielitz H; Chen M; Mericko P; Yang J; Sung DC; Lawton MT; Ruppert JM; Schwaninger M; Körbelin J; Potente M; Awad IA; Marchuk DA; Kahn ML
Nature; 2021 Jun; 594(7862):271-276. PubMed ID: 33910229
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Endothelial-to-Mesenchymal Transition to the Pathogenesis of Human Cerebral and Orbital Cavernous Malformations.
Takada S; Hojo M; Tanigaki K; Miyamoto S
Neurosurgery; 2017 Jul; 81(1):176-183. PubMed ID: 28368503
[TBL] [Abstract][Full Text] [Related]
15. Cerebral cavernous malformation proteins at a glance.
Draheim KM; Fisher OS; Boggon TJ; Calderwood DA
J Cell Sci; 2014 Feb; 127(Pt 4):701-7. PubMed ID: 24481819
[TBL] [Abstract][Full Text] [Related]
16. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth.
Zheng X; Xu C; Smith AO; Stratman AN; Zou Z; Kleaveland B; Yuan L; Didiku C; Sen A; Liu X; Skuli N; Zaslavsky A; Chen M; Cheng L; Davis GE; Kahn ML
Dev Cell; 2012 Aug; 23(2):342-55. PubMed ID: 22898778
[TBL] [Abstract][Full Text] [Related]
17. Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins.
Renz M; Otten C; Faurobert E; Rudolph F; Zhu Y; Boulday G; Duchene J; Mickoleit M; Dietrich AC; Ramspacher C; Steed E; Manet-Dupé S; Benz A; Hassel D; Vermot J; Huisken J; Tournier-Lasserve E; Felbor U; Sure U; Albiges-Rizo C; Abdelilah-Seyfried S
Dev Cell; 2015 Jan; 32(2):181-90. PubMed ID: 25625207
[TBL] [Abstract][Full Text] [Related]
18. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.
Choi JP; Wang R; Yang X; Wang X; Wang L; Ting KK; Foley M; Cogger V; Yang Z; Liu F; Han Z; Liu R; Baell J; Zheng X
Sci Adv; 2018 Nov; 4(11):eaau0731. PubMed ID: 30417093
[TBL] [Abstract][Full Text] [Related]
19. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.
Cullere X; Plovie E; Bennett PM; MacRae CA; Mayadas TN
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14284-9. PubMed ID: 26540726
[TBL] [Abstract][Full Text] [Related]
20. ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway.
Rosen JN; Sogah VM; Ye LY; Mably JD
Dev Biol; 2013 Apr; 376(1):74-85. PubMed ID: 23328253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
